We further investigated the potential effect mechanism of CO in HFD-induced dyslipidemia, which is probably closely linked with the metabolism of the lipid, particularly, the mammalian target of the rapamycin (mTOR) signal pathway and gut microbiota-mediated inhibition of lipid synthesis. Here, MTOR is linked to metabolic syndrome.